Study of Ifinatamab Deruxtecan (DS-7300a, I-DXd) in Participants With Advanced Solid Malignant Tumors

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Study of Ifinatamab Deruxtecan (DS-7300a, I-DXd) in Participants With Advanced Solid Malignant Tumors	neoplasm	Active, not recruiting	Phase 1 / Phase 2	2026-10-06		NCT04145622

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Daiichi Sankyo	144
Merck Sharp & Dohme LLC	650

23 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Aichi Cancer Center Hospital	Aichi	Japan	6
Cancer Institute Hospital of JFCR	Tokyo	Japan	12
Dana Farber Cancer Institute	Boston	United States	133
Florida Cancer Specialists	Sarasota	United States	47
Henry Ford Hospital	Detroit	United States	326
Hokkaido University Hospital	Hokkaido	Japan	14
John Theurer Cancer Center at Hackensack University Medical Center	Hackensack	United States	37
Kagawa University Hospital	Kagawa	Japan	6
Keio University Hospital	Tokyo	Japan	14
Kindai University Hospital	Ōsaka-sayama	Japan	13
Kobe City Medical Center General Hospital	Hyōgo	Japan	7
MDACC (MD Anderson Cancer Center)	Houston	United States	1
Memorial Sloan-Kettering Cancer Center	New York	United States	63
National Cancer Center Hospital	Tokyo	Japan	42
National Cancer Center Hospital East	Chiba	Japan	25
Saitama Cancer Center	Saitama	Japan	12
Sarah Cannon Research Institute at HealthOne	Denver	United States	34
Scri Oncology Partners	Nashville	United States	156
Shizuoka Cancer Center	Shizuoka	Japan	19
Showa Medical University Hospital	Tokyo	Japan	7
Tennessee Oncology	Nashville	United States	77
The University of Osaka Hospital	Osaka	Japan	12
Washington University	St Louis	United States	182

Clinical trials